The aberrant expression of TOP2A is intimately associated with the proliferation, motility, invasion, and epithelial–mesenchymal transition (EMT) events of liver cancer, as well as the poor prognosis of patients with liver cancer, and indicates a possible therapeutic target for liver cancer11. The gene discussed is TOP2A; the disease is liver cancer.